FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to gastroenterology, and concerns treating gastrointestinal disorders. That is ensured by administration of the effective amount of a halogenated prostaglandin compound and/or its tautomer.
EFFECT: method provides effective treatment in patients of any age and sex without involving electrolyte balance even in long-term introduction for 1 to 6 months and more.
54 cl, 8 tbl, 14 dwg, 6 ex
Authors
Dates
2010-06-27—Published
2005-09-01—Filed